TIAA CREF Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-509,592
| Closed | -$6.34M | – | 3124 |
|
|
2016
Q4 | $6.34M | Sell |
509,592
-36,708
| -7% | -$442K | ﹤0.01% | 1450 |
|
|
2016
Q3 | $7.48K | Sell |
546,300
-30,378
| -5% | -$305K | ﹤0.01% | 1314 |
|
|
2016
Q2 | $4.26M | Buy |
576,678
+16,539
| +3% | +$124K | ﹤0.01% | 1655 |
|
|
2016
Q1 | $3.58M | Sell |
560,139
-100,370
| -15% | -$563K | ﹤0.01% | 1725 |
|
|
2015
Q4 | $4.13M | Sell |
660,509
-85,124
| -11% | -$559K | ﹤0.01% | 1696 |
|
|
2015
Q3 | $4.35M | Sell |
745,633
-72,971
| -9% | -$562K | ﹤0.01% | 1626 |
|
|
2015
Q2 | $6.77M | Buy |
818,604
+12,031
| +1% | +$106K | ﹤0.01% | 1445 |
|
|
2015
Q1 | $6.65M | Buy |
806,573
+2,174
| +0.3% | +$16.1K | ﹤0.01% | 1432 |
|
|
2014
Q4 | $5.53M | Sell |
804,399
-39,922
| -5% | -$250K | ﹤0.01% | 1565 |
|
|
2014
Q3 | $4.56M | Sell |
844,321
-27,496
| -3% | -$161K | ﹤0.01% | 1673 |
|
|
2014
Q2 | $5.55M | Buy |
871,817
+586,548
| +206% | +$4.03M | ﹤0.01% | 1618 |
|
|
2014
Q1 | $2.3M | Buy |
285,269
+258,770
| +977% | +$2.02M | ﹤0.01% | 2159 |
|
|
2013
Q4 | $181K | Sell |
26,499
-1,011,190
| -97% | -$5.46M | ﹤0.01% | 3089 |
|
|
2013
Q3 | $19.1M | Sell |
1,037,689
-281,746
| -21% | -$5.47M | 0.01% | 771 |
|
|
2013
Q2 | $23.1M | Buy |
+1,319,435
| New | +$23.4M | 0.02% | 678 |
|
Other funds holding ARIA
TIAA CREF Investment Management's ARIA Position: Q1 2017 in Review
TIAA CREF Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 509,592 shares — an estimated $6.34M sold.
TIAA CREF Investment Management first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $23.1M in Q2 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- TIAA CREF Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- TIAA CREF Investment Management sold 509,592 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $6.34M.
- TIAA CREF Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- TIAA CREF Investment Management's Ariad Pharmaceuticals Inc position peaked at $23.1M in Q2 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on TIAA CREF Investment Management's 13F filing for Q1 2017, filed 11 May 2017.